NASDAQ:APDN Applied DNA Sciences (APDN) Stock Price, News & Analysis → Hurry! Buy this stock before the Robinhood traders do! (From Traders Agency) (Ad) Free APDN Stock Alerts $0.54 -0.01 (-0.94%) (As of 06/7/2024 08:51 PM ET) Add Compare Share Share Today's Range$0.50▼$0.5850-Day Range$0.51▼$8.8052-Week Range$0.50▼$37.20Volume2.14 million shsAverage Volume265,432 shsMarket Capitalization$529,200.00P/E RatioN/ADividend YieldN/APrice Target$7.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends Get Applied DNA Sciences alerts: Email Address Applied DNA Sciences MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside1,196.3% Upside$7.00 Price TargetShort InterestBearish18.04% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews SentimentN/AInsider TradingN/AProj. Earnings GrowthGrowingFrom ($6.54) to ($2.41) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.1.33 out of 5 stars 3.5 Analyst's Opinion Consensus RatingApplied DNA Sciences has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Amount of Analyst CoverageApplied DNA Sciences has only been the subject of 1 research reports in the past 90 days.Read more about Applied DNA Sciences' stock forecast and price target. Previous Next 2.0 Short Interest Percentage of Shares Shorted18.04% of the float of Applied DNA Sciences has been sold short.Short Interest Ratio / Days to CoverApplied DNA Sciences has a short interest ratio ("days to cover") of 2.3, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Applied DNA Sciences has recently increased by 399.37%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldApplied DNA Sciences does not currently pay a dividend.Dividend GrowthApplied DNA Sciences does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for APDN. Previous Next 0.6 News and Social Media Coverage Search Interest5 people have searched for APDN on MarketBeat in the last 30 days. This is an increase of 25% compared to the previous 30 days.MarketBeat FollowsOnly 2 people have added Applied DNA Sciences to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days. Previous Next 0.8 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Applied DNA Sciences insiders have not sold or bought any company stock.Percentage Held by Insiders10.25% of the stock of Applied DNA Sciences is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 22.22% of the stock of Applied DNA Sciences is held by institutions.Read more about Applied DNA Sciences' insider trading history. Previous Next 1.3 Earnings and Valuation Earnings GrowthEarnings for Applied DNA Sciences are expected to grow in the coming year, from ($6.54) to ($2.41) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Applied DNA Sciences is -0.03, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Applied DNA Sciences is -0.03, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioApplied DNA Sciences has a P/B Ratio of 0.08. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Applied DNA Sciences' valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Paradigm PressDems have chosen Biden replacement?On November 16, 2023… Joe Biden accidentally revealed the name of the candidate… Who will replace him in the 2024 presidential election.See who it is HERE. About Applied DNA Sciences Stock (NASDAQ:APDN)Applied DNA Sciences, Inc., a biotechnology company, develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) in the Americas, Europe, Asia, and internationally. It operates through three segments: Therapeutic DNA Production Services; MDx Testing Services; and DNA Tagging and Security Products and Services. The Therapeutic DNA Production Services segment develops and commercializes the LinearDNA platform, which enables a cell-free manufacture of high-fidelity synthetic DNA sequences for use in nucleic acid-based therapeutics. The MDx Testing Services segment provides clinical molecular diagnostics (MDx) testing and clinical laboratory testing services; COVID-19 testing services, including test scheduling, sample collection, and automated results reporting for higher education institutions, private clients, and businesses under the safeCircle trademark; polymerase chain reaction (PCR) for production and detection of DNA and RNA; and MDx test kits and related supplies, as well as Isotopic analysis testing services. The DNA Tagging and Security Products and Services segment offers SigNature Molecular Tags, which provides a methodology to authenticate goods within large and complex supply chains for materials, such as cotton, nutraceuticals, and other products; SigNify portable DNA readers and SigNify consumable reagent test kits; and fiberTyping, which uses PCR-based DNA detection to detect a product's naturally occurring DNA sequences for the purposes of product provenance authentication and supply chain security. The company was formerly known as Datalink Systems, Inc. and changed its name to Applied DNA Sciences, Inc. in 2002. Applied DNA Sciences, Inc. was founded in 1983 and is headquartered in Stony Brook, New York.Read More APDN Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart APDN Stock News HeadlinesJune 1, 2024 | americanbankingnews.comApplied DNA Sciences (NASDAQ:APDN) Now Covered by Analysts at StockNews.comMay 28, 2024 | finanznachrichten.deApplied DNA Sciences, Inc.: Applied DNA Announces Pricing of $12 Million Public OfferingMay 28, 2024 | msn.comApplied DNA stock plunges after pricing $12M securities offeringMay 28, 2024 | finance.yahoo.comApplied DNA Sciences Prices $12 Million Public Offering of UnitsMay 15, 2024 | morningstar.comApplied DNA Sciences IncMay 12, 2024 | finance.yahoo.comApplied DNA Sciences Second Quarter 2024 Earnings: Misses ExpectationsMay 10, 2024 | investorplace.comAPDN Stock Earnings: Applied DNA Sciences Beats EPS, Misses Revenue for Q2 2024May 10, 2024 | chron.comApplied DNA Sciences: Fiscal Q2 Earnings SnapshotMay 7, 2024 | reuters.comBanned Chinese cotton found in 19% of US retailers' merchandise, study showsMay 7, 2024 | finance.yahoo.comCORRECTED-Banned Chinese cotton found in 19% of US and global retailers' merchandise, study showsMay 7, 2024 | finance.yahoo.comBanned Chinese cotton found in 19% of US and global retailers' merchandise, study showsApril 26, 2024 | finanznachrichten.deApplied DNA Sciences, Inc.: Applied DNA Awarded Contract by HDT Bio For Rapid Vaccine Development ProgramMarch 14, 2024 | finanznachrichten.deApplied DNA Sciences, Inc.: Applied DNA to Showcase Linea DNA and Linea IVT Platforms at 24th Annual World Vaccine CongressMarch 12, 2024 | msn.comApplied DNA Sciences files to sell 11.29M shares of common stock for holdersFebruary 24, 2024 | msn.comApplied DNA Sciences (APDN) Price Target Increased by 12.50% to 2.30February 23, 2024 | benzinga.comApplied DNA Sciences Stock (NASDAQ:APDN) Earnings Dates and Earning CallsFebruary 22, 2024 | wsj.comApplied DNA Sciences Inc.February 22, 2024 | benzinga.comApplied DNA Sciences Stock (NASDAQ:APDN) Dividends: History, Yield and DatesFebruary 10, 2024 | finance.yahoo.comApplied DNA Sciences First Quarter 2024 Earnings: Beats ExpectationsFebruary 10, 2024 | insidermonkey.comApplied DNA Sciences, Inc. (NASDAQ:APDN) Q1 2024 Earnings Call TranscriptFebruary 9, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Applied DNA Sciences (APDN) and Viking Therapeutics (VKTX)February 9, 2024 | finance.yahoo.comQ1 2024 Applied DNA Sciences Inc Earnings CallFebruary 8, 2024 | finanznachrichten.deApplied DNA Sciences, Inc.: Applied DNA Announces First Quarter Fiscal Year 2024 Financial ResultsFebruary 8, 2024 | benzinga.comRecap: Applied DNA Sciences Q1 EarningsFebruary 8, 2024 | markets.businessinsider.comApplied DNA Announces First Quarter Fiscal Year 2024 Financial ResultsSee More Headlines Receive APDN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Applied DNA Sciences and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/10/2024Today6/09/2024Next Earnings (Estimated)8/08/2024Fiscal Year End9/30/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorIndustrial Products Industry Testing laboratories Sub-IndustryN/A Current SymbolNASDAQ:APDN CUSIPN/A CIK744452 Webwww.adnas.com Phone(631) 240-8800Fax631-240-8900Employees52Year FoundedN/APrice Target and Rating Average Stock Price Target$7.00 High Stock Price Target$7.00 Low Stock Price Target$7.00 Potential Upside/Downside+1,196.3%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)($17.11) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-9,950,000.00 Net Margins-222.33% Pretax Margin-223.88% Return on Equity-306.32% Return on Assets-101.11% Debt Debt-to-Equity RatioN/A Current Ratio1.66 Quick Ratio1.54 Sales & Book Value Annual Sales$13.37 million Price / Sales0.04 Cash FlowN/A Price / Cash FlowN/A Book Value$7.13 per share Price / Book0.08Miscellaneous Outstanding Shares980,000Free Float884,000Market Cap$529,200.00 OptionableOptionable Beta0.08 7 Energy Stocks to Buy and Hold ForeverDo you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.Get This Free Report Key ExecutivesDr. James A. Hayward Ph.D. (Age 70)Sc.D., Chairman, President & CEO Comp: $468kMs. Judith Murrah (Age 66)COO, Chief Information Officer & Secretary Comp: $325kMr. Clay Shorrock Esq. (Age 39)J.D., Chief Legal Officer & Executive Director of Business Development Comp: $300kMr. Sanjay M. HurryExecutive Director of Investor Relations & Corporate CommunicationsKey CompetitorsAltisource Portfolio SolutionsNASDAQ:ASPSPerformant FinancialNASDAQ:PFMTNV5 GlobalNASDAQ:NVEEDonnelley Financial SolutionsNYSE:DFINUL SolutionsNYSE:ULSView All CompetitorsInstitutional OwnershipAMH Equity LtdBought 170,385 shares on 5/7/2024Ownership: 63.575%View All Institutional Transactions APDN Stock Analysis - Frequently Asked Questions Should I buy or sell Applied DNA Sciences stock right now? 1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Applied DNA Sciences in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" APDN shares. View APDN analyst ratings or view top-rated stocks. What is Applied DNA Sciences' stock price target for 2024? 1 equities research analysts have issued 1-year price targets for Applied DNA Sciences' shares. Their APDN share price targets range from $7.00 to $7.00. On average, they anticipate the company's share price to reach $7.00 in the next year. This suggests a possible upside of 1,196.3% from the stock's current price. View analysts price targets for APDN or view top-rated stocks among Wall Street analysts. How have APDN shares performed in 2024? Applied DNA Sciences' stock was trading at $12.3360 at the beginning of 2024. Since then, APDN stock has decreased by 95.6% and is now trading at $0.54. View the best growth stocks for 2024 here. Are investors shorting Applied DNA Sciences? Applied DNA Sciences saw a increase in short interest during the month of May. As of May 15th, there was short interest totaling 158,800 shares, an increase of 399.4% from the April 30th total of 31,800 shares. Based on an average daily volume of 69,200 shares, the days-to-cover ratio is presently 2.3 days. Currently, 18.0% of the company's stock are short sold. View Applied DNA Sciences' Short Interest. When is Applied DNA Sciences' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, August 8th 2024. View our APDN earnings forecast. How were Applied DNA Sciences' earnings last quarter? Applied DNA Sciences, Inc. (NASDAQ:APDN) issued its earnings results on Friday, May, 10th. The technology company reported ($5.31) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($4.60) by $0.71. The technology company earned $0.93 million during the quarter, compared to analysts' expectations of $0.90 million. Applied DNA Sciences had a negative trailing twelve-month return on equity of 306.32% and a negative net margin of 222.33%. When did Applied DNA Sciences' stock split? Shares of Applied DNA Sciences reverse split on Thursday, April 25th 2024. The 1-20 reverse split was announced on Thursday, April 25th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, April 25th 2024. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split. What is James A. Hayward's approval rating as Applied DNA Sciences' CEO? 2 employees have rated Applied DNA Sciences Chief Executive Officer James A. Hayward on Glassdoor.com. James A. Hayward has an approval rating of 100% among the company's employees. This puts James A. Hayward in the top 10% of approval ratings compared to other CEOs of publicly-traded companies. 100.0% of employees surveyed would recommend working at Applied DNA Sciences to a friend. What other stocks do shareholders of Applied DNA Sciences own? Based on aggregate information from My MarketBeat watchlists, some companies that other Applied DNA Sciences investors own include Inovio Pharmaceuticals (INO), Advanced Micro Devices (AMD), Ekso Bionics (EKSO), Micron Technology (MU), Arbutus Biopharma (ABUS), VBI Vaccines (VBIV), Gilead Sciences (GILD), Vaxart (VXRT), Sorrento Therapeutics (SRNE) and Intel (INTC). Who are Applied DNA Sciences' major shareholders? Applied DNA Sciences' stock is owned by many different institutional and retail investors. Top institutional shareholders include AMH Equity Ltd (63.57%) and Concourse Financial Group Securities Inc. (0.00%). View institutional ownership trends. How do I buy shares of Applied DNA Sciences? Shares of APDN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:APDN) was last updated on 6/10/2024 by MarketBeat.com Staff From Our PartnersWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredIt's time to ween off Chinese lithium!As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promi...Smallcaps Daily | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | SponsoredRSVP: Charles Payne’s Cash Flow WorkshopDid you know you could "cash flow" the stocks in your portfolio? Without selling a single share of stock? ...Unstoppable Prosperity | SponsoredBuy this small stock before coming AI Tidal WaveThe internet generated more wealth than any other innovation in history - creating hundreds of thousands of ne...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Applied DNA Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Applied DNA Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.